Symbiosis are attending Cell & Gene Therapy International 2026 in Boston, 23rd – 25th September.
Cell & Gene Therapy International brings together experts from across the advanced therapies landscape to explore the latest developments in cell and gene therapy bioprocessing, manufacturing and regulatory strategy. As the sector evolves at pace, the need for reliable, experienced manufacturing partners has never been greater.
At Symbiosis, we support innovators in translating complex injectable biologics and advanced therapies from development through to clinical trial and commercial manufacture, delivering expertise, flexibility and quality at every stage.
Supporting the next generation of advanced therapies
Cell and gene therapies present unique manufacturing challenges. At Symbiosis we work collaboratively with clients to navigate these challenges, offering a tailored approach to sterile manufacture. Operating from our MHRA-licensed and FDA inspected facilities in Stirling, UK, we provide a fully integrated service that ensures continuity and confidence throughout the manufacturing lifecycle.
